The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in income, its patent expiration created a deluge of lower-priced alternatives , significantly eroding its position . While certain firms may try to capitalize on similar conditions , the current landsca